The Scientist

» obituary and disease/medicine

Most Recent

image: Those We Lost in 2016

Those We Lost in 2016

By | December 23, 2016

The scientific community bid farewell to several luminaries this year.

1 Comment

image: Ignacio Tinoco, Luminary of RNA Folding, Dies

Ignacio Tinoco, Luminary of RNA Folding, Dies

By | December 20, 2016

The chemist shed light on ribonucleic acids’ secondary structures.

0 Comments

image: Henry Heimlich, Maneuver Inventor, Dies

Henry Heimlich, Maneuver Inventor, Dies

By | December 20, 2016

The famed surgeon, whose signature maneuver to clear the blockage in a choking victim’s throat, helped save thousands of lives.

0 Comments

image: Former WHO Director-General Dies

Former WHO Director-General Dies

By | December 16, 2016

Halfdan Mahler, the third leader of the World Health Organization, has passed away at age 93.

0 Comments

image: Famed Pediatric Endocrinologist Dies

Famed Pediatric Endocrinologist Dies

By | December 6, 2016

Melvin Grumbach, a clinician and researcher who described the hormonal dynamics of puberty and numerous endocrine disorders, has passed away at age 90.

0 Comments

image: USC Professor Fatally Stabbed

USC Professor Fatally Stabbed

By | December 5, 2016

Psychologist Bosco Tjan of the University of Southern California studied how people adapt as they lose their vision.  

0 Comments

image: Former NSF Director Dies

Former NSF Director Dies

By | December 5, 2016

Erich Bloch, a Holocaust refugee who rose to prominence as director of the National Science Foundation, has passed away at age 91.

0 Comments

image: Famed Mammalian Embryologist Dies

Famed Mammalian Embryologist Dies

By | December 2, 2016

Andrzej Tarkowski’s research laid the groundwork for future advances in cloning, stem cell research, and in vitro fertilization.

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | December 1, 2016

The importance of science innovation, publishing and gender, and more

1 Comment

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

Popular Now

  1. Unstructured Proteins Help Tardigrades Survive Desiccation
  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Opinion: On “The Impact Factor Fallacy”
  4. Inflammation Drives Gut Bacteria Evolution
Business Birmingham